Department of Biochemistry, Dongeui University College of Korean Medicine, Busan 47227, Republic of Korea.
Department of Parasitology and Genetics, Kosin University College of Medicine, Busan 49267, Republic of Korea.
Int J Mol Med. 2018 Jan;41(1):264-274. doi: 10.3892/ijmm.2017.3209. Epub 2017 Oct 25.
Schisandrin A is a bioactive lignan occurring in the fruits of plants of the Schisandra genus that have traditionally been used in Korea for treating various inflammatory diseases. Although the anti-inflammatory and antioxidant effects of lignan analogues similar to schisandrin A have been reported, the underlying molecular mechanisms have remained elusive. In the present study, schisandrin A significantly suppressed the lipopolysaccharide (LPS)-induced production of the key pro-inflammatory mediators nitric oxide (NO) and prostaglandin E2 by suppressing the expression of inducible NO synthase and cyclooxygenase-2 at the mRNA and protein levels in RAW 264.7 macrophages. Furthermore, schisandrin A was demonstrated to reduce the LPS-induced secretion of pro-inflammatory cytokines, including tumor necrosis factor-α and interleukin-1β; this was accompanied by a simultaneous decrease in the respective mRNA and protein levels in the macrophages. In addition, the LPS- induced translocation of nuclear factor-κB (NF-κB), as well as activation of mitogen-activated protein kinases (MAPKs) and phosphatidylinositol‑3 kinase (PI3K)/Akt pathways were inhibited by schisandrin A. Furthermore, schisandrin A significantly diminished the LPS-stimulated accumulation of intracellular reactive oxygen species, and effectively enhanced the expression of NF erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). These results suggested that schisandrin A has a protective effect against LPS-induced inflammatory and oxidative responses in RAW 264.7 cells by inhibiting the NF-κB, MAPK and PI3K/Akt pathways; these effects are mediated, at least in part, by the activation of the Nrf2/HO-1 pathway. Based on these results, it is concluded that schisandrin A may have therapeutic potential for treating inflammatory and oxidative disorders caused by over-activation of macrophages.
五味子 A 是一种生物活性木质素,存在于五味子属植物的果实中,传统上用于治疗韩国的各种炎症性疾病。虽然与五味子 A 类似的木质素类似物具有抗炎和抗氧化作用,但潜在的分子机制仍不清楚。在本研究中,五味子 A 通过抑制诱导型一氧化氮合酶和环氧合酶-2 在 RAW 264.7 巨噬细胞中的 mRNA 和蛋白质水平的表达,显著抑制脂多糖 (LPS) 诱导的关键促炎介质一氧化氮 (NO) 和前列腺素 E2 的产生。此外,五味子 A 被证明可减少 LPS 诱导的促炎细胞因子,包括肿瘤坏死因子-α和白细胞介素-1β的分泌;这伴随着巨噬细胞中相应的 mRNA 和蛋白质水平的同时降低。此外,LPS 诱导的核因子-κB (NF-κB) 易位以及丝裂原激活蛋白激酶 (MAPK) 和磷脂酰肌醇 3 激酶 (PI3K)/Akt 途径的激活均被五味子 A 抑制。此外,五味子 A 可显著减少 LPS 刺激的细胞内活性氧物质的积累,并有效增强 NF 红细胞 2 相关因子 2 (Nrf2) 和血红素加氧酶 1 (HO-1) 的表达。这些结果表明,五味子 A 通过抑制 NF-κB、MAPK 和 PI3K/Akt 途径对 RAW 264.7 细胞中的 LPS 诱导的炎症和氧化反应具有保护作用;这些作用至少部分是通过激活 Nrf2/HO-1 途径介导的。基于这些结果,可以得出结论,五味子 A 可能具有治疗由巨噬细胞过度激活引起的炎症和氧化紊乱的治疗潜力。